We are live on ! Find out more
IMA

ImageneBio Inc
IMA

52 hedge funds and large institutions have $52M invested in ImageneBio Inc in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

6% more capital invested

Capital invested by funds: $49.1M → $52M (+$2.86M)

0.93% more ownership

Funds ownership: 5.63% → 6.56% (+0.93%)

9% less funds holding

Funds holding: 57 → 52 (-5)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

55% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 20

Holders
52
Holders Change
-5
Holders Change %
-8.77%
% of All Funds
0.68%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
6
Increased
9
Reduced
20
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
BML Capital Management
Indiana
+$4.82M
2
JP Morgan Chase
JP Morgan Chase
New York
+$261K
3
UBS Group
UBS Group
Switzerland
+$121K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$95.9K
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$74.2K

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$1.28M
2
AI
Acuitas Investments
Washington
-$778K
3
FIA
FNY Investment Advisers
New York
-$400K
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$317K
5
VAM
Vazirani Asset Management
New York
-$153K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$8.23M – – –
BOCH
2
Blue Owl Capital Holdings
New York
$6.71M – – –
BI
3
BVF Inc
California
$6.57M -$1.28M -63,550 -16%
BCM
4
BML Capital Management
Indiana
$5.88M +$4.82M +238,548 +396%
O
5
OrbiMed
New York
$5.8M – – –
OFM
6
Omega Fund Management
Massachusetts
$3.69M – – –
GS
7
Gilead Sciences
California
$3.29M +$3.38M +167,362 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$2.27M – – –
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$1.31M -$317K -15,658 -19%
NMC
10
NEA Management Company
Maryland
$984K – – –
PLC
11
Peapod Lane Capital
New York
$833K +$856K +42,322 New
SI
12
Sofinnova Investments
California
$627K – – –
BlackRock
13
BlackRock
New York
$578K -$61 -3 -0%
Renaissance Technologies
14
Renaissance Technologies
New York
$542K -$119K -5,866 -18%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$538K +$95.9K +4,744 +21%
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$537K -$103K -5,112 -16%
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
$471K -$62.9K -3,112 -11%
Millennium Management
18
Millennium Management
New York
$327K -$83.8K -4,145 -20%
Barclays
19
Barclays
United Kingdom
$320K – – –
Two Sigma Advisers
20
Two Sigma Advisers
New York
$258K -$75.3K -3,725 -22%
JP Morgan Chase
21
JP Morgan Chase
New York
$255K +$261K +12,907 +18,179%
BCM
22
Bridgeway Capital Management
Texas
$252K -$7.74K -383 -3%
Two Sigma Investments
23
Two Sigma Investments
New York
$165K -$94.2K -4,661 -36%
State Street
24
State Street
Massachusetts
$151K +$19.9K +983 +15%
DCM
25
Deuterium Capital Management
Florida
$132K – – –
1
2 3

IMA Hedge Fund Activity: Q4 2024 in Review

52 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q4 2024, worth a combined $52M — up 5.8% from $49.1M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of IMA and 6 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 9 added.

The largest buyer was BML Capital Management, adding an estimated $4.82M. The largest seller was BVF Inc, cutting an estimated $1.28M.

  • 52 institutional investors held ImageneBio Inc (IMA) as of Q4 2024, down from 57 in Q3 2024.
  • Funds reported $52M of ImageneBio Inc stock for Q4 2024, up 5.8% quarter-over-quarter.
  • 6 funds opened new ImageneBio Inc positions in Q4 2024 and 11 closed out, a net change of -5 holders.
  • The largest ImageneBio Inc buyer in Q4 2024 was BML Capital Management, an estimated $4.82M added.
  • The largest ImageneBio Inc seller in Q4 2024 was BVF Inc, an estimated $1.28M sold.

Based on aggregated 13F filings for Q4 2024.